Literature DB >> 1120301

Repair of radiation damage in Lewis lung carcinoma cells following in situ treatment with fast neutrons and gamma-rays.

W U Shipley, J A Stanley, V D Courtenay, S B Field.   

Abstract

Lewis lung tumor cells were irradiated with 60Co gamma-rays or cyclotron-produced neutrons in situ as solid s.c. tumors or in vitro as single cell suspensions. Cell survival was assayed by colony formation both in vitro in soft agar and in the lungs of isogeneic recipient mice. Survival curve characteristics measured in vitro were: Do = 111 rads, Dq = 342 rads, n = 22 for gamma-rays, and Do = 61 rads, Dq = 46 rads, n = 2 for neutrons. In situ, the hypoxic fraction was 0.36. Irradiation in situ gave, for the hypoxic subpopulation, Do = 315 rads for gamma-rays and Do = 91 rads for neutrons. The oxygen-enhancement ratio for gamma-rays was 2.8 and for neutrons was 1.5. Using the split-dose technique, in which two equal doses were administered, separated by 4 hr chronically hypoxic tumor cells repaired sublethal damage, assayed by leaving tumor cells in situ up to 24 hr posttreatment, could not be detected after neutrons, but after gamma-rays it was observed as a 3- to 6-fold increase in survival. The repair of potentially lethal damage increased the relative biological effectiveness of neutrons from 3.7 at a survival level of 5% when assayed immediately after treatment to 4.7 when assayed 6 to 24 hr after treatment. These observations, primarily limited to the chronically hypoxic subpopulation of tumor cells, suggest that decreased repair of potentially lethal damage as well as sublethal damage may be an important radiobiological difference between the effects of high and low linear energy transfer radiation.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1120301

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  11 in total

1.  [Scalpel and CO2 laser in the animal experiment. A comparative study of inoculation tumors of the mouse].

Authors:  A Tuchmann; P L Fischer; P Bauer; H Plenk; O Braun; K Dinstl
Journal:  Langenbecks Arch Chir       Date:  1986

Review 2.  Tumor hypoxia: its impact on cancer therapy.

Authors:  J E Moulder; S Rockwell
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

Review 3.  Can dose-survival parameters be deduced from in situ assays?

Authors:  T E Wheldon
Journal:  Br J Cancer Suppl       Date:  1980-04

4.  Radiobiological studies of tumours in situ compared with cell survival.

Authors:  N J McNally; J de Ronde
Journal:  Br J Cancer Suppl       Date:  1980-04

5.  Clonogenic assays in the B16 melanoma: response to cyclophosphamide.

Authors:  G G Steel; K Adams; T C Stephens
Journal:  Br J Cancer       Date:  1977-11       Impact factor: 7.640

6.  Radiosensitization by CpG ODN7909 in an epidermoid laryngeal carcinoma Hep-2 cell line.

Authors:  Shu Wang; Xiaoqun Liu; Tiankui Qiao; Qi Zhang
Journal:  J Int Med Res       Date:  2017-09-18       Impact factor: 1.671

7.  A soft agar colony assay for Lewis lung tumour and B16 melanoma taken directly from the mouse.

Authors:  V D Courtenay
Journal:  Br J Cancer       Date:  1976-07       Impact factor: 7.640

8.  Cellular repair factors influencing radiocurability of human malignant tumours.

Authors:  R R Weichselbaum; A Schmit; J B Little
Journal:  Br J Cancer       Date:  1982-01       Impact factor: 7.640

9.  The differential response of human tumours to fractionated radiation may be due to a post-irradiation repair process.

Authors:  R R Weichselbaum; J B Little
Journal:  Br J Cancer       Date:  1982-10       Impact factor: 7.640

10.  Repopulation of gamma-irradiated Lewis lung carcinoma by malignant cells and host macrophage progenitors.

Authors:  T C Stephens; G A Currie; J H Peacock
Journal:  Br J Cancer       Date:  1978-11       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.